Study Of Nerve Conduction Velocity In Type II Diabetes Mellitus

Study Of Nerve Conduction Velocity In Type II Diabetes Mellitus

Authors

  • Nidhi Yadav
  • Anjali Shete
  • Prashant Yadav
  • Nisha Yadav
  • S.T. Khan

Keywords:

Diabetes Mellitus, Glycated haemoglobin, Nerve Conduction Velocity

Abstract

Background& Objectives: Diabetic neuropathy is the most common and troublesome complication of diabetes mellitus, leading to great morbidity and resulting in burden for diabetes care. The progression of neuropathy can be reduced by early detection and intervention. Nerve conduction studies are the most sensitive indices of the severity of neuropathy. These tests can be used to localize lesions and describe the type and severity of the pathophysiologic process, including alterations that are not recognized clinically. This study was undertaken to compare nerve conduction study results in diabetes mellitus patients with good glycemic control and poor glycemic control and to compare it with non-diabetic subjects. This study aims to signify the role of nerve conduction study in diabetes mellitus. This can help in identifying the asymptomatic stage of diabetic neuropathy so that suitable preventive measures can be taken. Methodology: Total 90 subjects were included in the study group. 30 were non diabetic subjects and 60 were known cases of Type II diabetes mellitus patients attending diabetic OPD at GMCH, Aurangabad of age 30-50 years with duration of 5-10 years. Glycated haemoglobin levels were estimated and on this basis the cases were divided into two groups; diabetic patients with good glycemic control and diabetic patients with poor glycemic control. Nerve Conduction parameters were measured by computerized micromed RMSEMG system. Results: There was an increase in mean latency and decrease in amplitude and velocity values in both the diabetic groups. Intergroup comparison showed that, the increase in latency and decrease in amplitude and velocity was more in diabetics with poor glycemic control as compared to other study groups and this difference was statistically highly significant. Conclusion: The study concluded that there is statistically significant changes in nerve conduction parameters in Type II diabetes. [Yadav N NJIRM 2015; 6(4): 36-43]

References

1. Alvin C Powers. Editors: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al. Diabetes Mellitus Harrison’s Principles of Internal Medicine, 17th edition. New York: The McGraw-Hill, health professions division; 2008.p. 2275-304.
2. Guyton AC, Hall JE. In: Insulin glucagon and diabetes mellitus, Textbook of Medical Physiology. Saunder’sPhiladelphia 12th edition; 2013. p. 618- 622.
3. Park K. Park’s Textbook of Preventive and Social Medicine 22nd edition. Jabalpur: M/S BanarsidasBhanot Publishers; 2013. p. 362-367.
4. Frier BM, Fisher M. In: Diabetes mellitus. Davidson’s principles and practice of medicine. 21st edition. Editors: Nicki RC, Brian RW, Stuart HR. Churchill Livingstone Elsevier; 2010. p. 796-830.
5. Fowler MJ. Microvascular andmacrovascular complications of diabetes. Clinical diabetes. 2008 Nov 2; 26 :77-82.
6. Shekharappa KR, Srinivas AK, Vedavathi KJ, Venkatesh G. A Study on the utility of nerve conduction studies in type 2 diabetes mellitus. Journal of clinical and diagnostic research. 2011 Jun; 5(3):529-531.
7. Al- Ani FS, Al- Nimer MS and Ali FS. Dyslipidaemia as a contributory factor in etiopathogenesis of diabetic neuropathy. Indian J EndocrinolMetab. 2011 Apr; 15(2):110-4.
8. Bansal V, Kalita J, Mishra UK. Diabetic neuropathy. Postgrad Med J. 2006; 82: 95-100.
9. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA et al. Diabetic neuropathies : A statement by the American Diabetes Association. Diabetes Care. 2005 Apr; 28(4): 956-962.
10. LeRoith D, Taylor SI, Olefsky JM. Diabetes Mellitus. A Fundamental and Clinical Text. Diabetic neuropathies: An overview of clinical aspects, pathogenesis and treatment. 3rdEdition. Lippincott Williams and Wilkins; 2004. P.1331-1363.
11. Sultana S, Begum N, Ali L, Hossain MM, Bhomik NB, Parveen Z. Electrophysiological changes of motor nerves in patients with type 2 diabetes mellitus. JAFMC Bangladesh. 2009 Dec; 5 (2): 14-17.
12. UK Mishra, J Kalita, Nerve Conduction Study. Clinical Neurophysiology, second edition. Elsevier. 2012.
13. Nathan, D.M., . The Clinical information value of the glycosylated Assay. The New England Journal of Medicine. 1984; 310: 341- 346.
14. Tavakoli M, Mojaddidi M, Fadavi H, Malik R.A. Pathophysiology and treatmentof painful diabetic neuropathy. Current Pain and Headache Reports. 2008; 12: 192-197.
15. Dunnigan KS, Ebadi H, Breiner A, Katzberg HD, Lovblom LE, Perkins BA, Bril V. Conduction slowing in diabetic sensorimotor Polyneuropathy. Diabetes care.2013 Sep 11:1-7
16. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry. 1977 Nov; 40(11): 1072-82.
17. Gk pal, Pravati Pal. Nerve Conduction Study, practical Physiology, 3rdedition. Orient Longman Private Ltd; 2011. p. 215-222.
18. Abdulsalam A, Al-Sulaiman, Ismail HM, Al- Sultan AI. Electrophysiological findings in newly diagnosed non insulin – dependent diabetics: A prospective study. Annals of Saudi Medicine 1997; 17(4): 399-401.
19. Parveenkumar, Michael clark. Diabetes mellitus and other disorders of metabolism, clinical medicine. Sixth edition. Saunders Elsevier; 2005. p. 1101-1134.
20. Clayton W, Elasy TA. A review of the pathophysiology, classification and treatment of foot ulcers in diabetic patients. Clinical Diabetes.2009; 27(2): 52-58.
21. Malik RA. The Pathology of human Diabetic neuropathy. Diabetes. 1997 Sep; 46(2): 50-53.
22. Goldman L, Ausiello D. Type 1 diabetes mellitus, Cecil Medicine, 23rdEdition, Volume –II Section XVII to XXVIII. Saunders Elsevier; 2003. p. 1742.
23. Stratton IM, Adler AI, Neil AW, Matthews DR, Manley SE, Cull CA, Hadden D et al. Association of Glycemia with macrovascular and microvascular complications of type 2 diabetes
mellitus (UKPDS 35): Prospective observational study. BMJ. 2000 Aug 12; 321: 405-12.
24. Pop-Busui R, Lu J, Brooks MM, Albert S, Althouse AD, Jorge Escobedo et al. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2 D) Cohort. Diabetes Care. 2013 Oct; 36(10): 3208-3215.
25. Viswanathan V, Seena R, Nair MB, Snehalatha C, Bhoopathy RM, Ramachandran A. Nerve conduction abnormalities in different stages of glucose intolerance. Neurol India. 2004; 52(4): 466-469.
26. Baba M, Ozaki L. Electrophysiological changes in diabetic neuropathy: From subclinical alterations to disabling abnormalities. Arch physiolbiochem. 2001 Jul; 109(3): 234-240.
27. Thrainsdottir S, Mallik RA, Dahlin LB, Wiksell P, Eriksson KF, RosenI, et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes. 2003 Oct; 52: 2615-22.
28. Loseth S, Nebuchennykh M, Starlberg E, Mellgren SI. Medial plantar nerve conduction studies in healthy controls and diabetics. Clinical

Downloads

Published

2018-01-10

How to Cite

Yadav, N., Shete, A., Yadav, P., Yadav, N., & Khan, S. (2018). Study Of Nerve Conduction Velocity In Type II Diabetes Mellitus: Study Of Nerve Conduction Velocity In Type II Diabetes Mellitus. National Journal of Integrated Research in Medicine, 6(4), 36–43. Retrieved from http://nicpd.ac.in/ojs-/index.php/njirm/article/view/935

Issue

Section

Original Articles

Most read articles by the same author(s)